Dare Bioscience (DARE) FCF Margin (2014 - 2025)
Dare Bioscience's (DARE) quarterly FCF Margin came in at 107.71% in Q4 2025, up 761970.0% YoY from N/an in Q4 2024, and up 100.47% on a QoQ basis from 22761.14% in Q3 2025.
Dare Bioscience (DARE) FCF Margin (2014 - 2025) Analysis & Trends
Dare Bioscience (DARE) has 7 years of FCF Margin data on file, last reported at 107.71% in Q4 2025.
- Quarterly FCF Margin rose 761970.0% year-over-year to 107.71% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 997.01% (down 5108398.0% YoY) and the FY2025 annual result came in at 997.01%, down 5108398.0% from the prior year.
- FCF Margin climbed to 107.71% in Q4 2025, from 22761.14% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 57545.15% in Q2 2024 to a low of 73320.34% in Q1 2024.
- A 4-year average of 5253.67% and a median of 795.49% in 2023 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 5174695 bps in 2025, down 3216510 bps in 2025.
- Tracing DARE's FCF Margin over 4 years: stood at 84.45% in 2022, then plunged by 434 bps to 451.18% in 2023, then slumped by 1565 bps to 7511.99% in 2024, then surged by 101 bps to 107.71% in 2025.
- The last three FCF Margin figures came in at 107.71% (Q4 2025), 22761.14% (Q3 2025), and 25380.05% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Dare Bioscience | 11.91 Mn | -705,728.22 | -132,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 107.71% |
| Sep 30, 2025 | -22,761.14% |
| Jun 30, 2025 | 25,380.05% |
| Mar 31, 2025 | -21,573.39% |
| Dec 31, 2024 | -7,511.99% |
| Sep 30, 2024 | -14,325.32% |
| Jun 30, 2024 | 57,545.15% |
| Mar 31, 2024 | -73,320.34% |
| Dec 31, 2023 | -451.18% |
| Sep 30, 2023 | -795.49% |
| Jun 30, 2022 | -84.45% |
| Jun 30, 2017 | -17.07% |
| Mar 31, 2017 | -4.24% |
| Dec 31, 2016 | -26.50% |
| Jun 30, 2014 | -9,842.42% |
| Mar 31, 2014 | -9,968.09% |